Active Ingredient: OLUTASIDENIB
Proprietary Name: REZLIDHIA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215814
Product Number: 001
Approval Date: Dec 1, 2022
Applicant Holder Full Name: RIGEL PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
